New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
March 14, 2013
09:13 EDTONCYOncolytics Biotech reports FY12 EPS (C$0.48), consensus (43c)
Reports FY12 Research and development expensed C$31.4M.
News For ONCY From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
May 4, 2015
07:21 EDTONCYBloom Burton & Co to hold a conference
Subscribe for More Information
April 29, 2015
06:52 EDTONCYOncolytics0s Reolysin for pancreatic cancer given Orpan Drug status by EMA
Oncolytics Biotech's lead product candidate, Reolysin, for the treatment of pancreatic cancer, has been granted Orphan Drug Designation by the European Medicines Agency.
06:41 EDTONCYOncolytics granted ODD from EMA for Reolysin
Subscribe for More Information
April 20, 2015
06:36 EDTONCYOncolytics announces series of posters to be made at AACR Annual Meeting
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use